Mebfap
Pharmaceutical compound

Mebfap, also known as 1-(5-methoxybenzofuran-3-yl)-2-aminopropane or 5-methoxy-3-(2-aminopropyl)benzofuran (5-MeO-3-APB) as well as 1-oxa-5-MeO-AMT, is a serotonin receptor modulator of the benzofuran family related to the psychedelic tryptamine 5-MeO-AMT. It is the analogue and bioisostere of 5-MeO-AMT in which the nitrogen atom of the indole ring has been replaced with an oxygen atom, resulting in the drug being a benzofuran rather than tryptamine derivative. Mebfap is a ligand of serotonin receptors similarly to 5-MeO-AMT, but shows about 6-fold lower affinity than 5-MeO-AMT. It was first described in the scientific literature by David E. Nichols and colleagues by 1992.
Sources and credits
This article is adapted from the Wikipedia article “Mebfap”, written by its contributors and licensed under CC BY-SA 4.0. Fathomly has changed the layout, removed citation markers, navigation and maintenance notices, and adjusted punctuation. This adapted version is shared under the same license. For references, see the original article.
Images, from Wikimedia Commons:
- Mebfap 2D.svg by Wolren, Public domain
Fathomly is not affiliated with or endorsed by the Wikimedia Foundation. Spotted a problem? Tell us.